Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Shopping for a car lover isn’t nearly as difficult as it seems, especially when you focus on the small, useful gear they’ll actually appreciate.